Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations

被引:16
作者
Aziz, Abdel-ilah [1 ]
Nguyen, Long Chi [2 ]
Oumeslakht, Loubna [1 ]
Bensussan, Armand [1 ,3 ]
Ben Mkaddem, Sanae [1 ,4 ]
机构
[1] Mohammed VI Polytech Univ, Inst Biol & Med Sci, Ben Guerir, Morocco
[2] Univ Chicago, Ben May Dept Canc Res, Chicago, IL USA
[3] Hop St Louis, INSERM, UMRS976, Oncodermatol & Therapies, Paris, France
[4] Mohammed VI Polytech Univ, Inst Biol & Med Sci, Ben Guerir 43150, Morocco
关键词
cannabinoids; cannabidiol; chronic inflammatory disease; irritable bowel syndrome; COVID-19; cancer; neurological pathologies; CB2; RECEPTOR; ENDOCANNABINOID SYSTEM; PLANT CANNABINOIDS; CROHNS-DISEASE; IN-VITRO; EXPRESSION; PATHWAY; CANCER; CELLS; PHARMACOLOGY;
D O I
10.1089/can.2022.0133
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in Cannabis extracts. CBD has a binding affinity for several cannabinoid and cannabinoid-associated receptors. Epidiolex (oral CBD solution) has been lately licensed by the Food and Drug Administration (FDA) for the treatment of pediatric epileptic seizures.Methods: In this review, we discussed the most promising applications of CBD for chronic inflammatory conditions, namely CBD's anti-inflammatory effects during inflammatory bowel disease, coronavirus disease (antiviral effect), brain pathologies (neuroprotective and anti-inflammatory properties), as well as CBD immunomodulatory and antitumoral activities in the tumor microenvironment. Special focus was shed on the main therapeutic mechanisms of action of CBD, particularly in the control of the immune system and the endocannabinoid system.Results: Findings suggest that CBD is a potent immunomodulatory drug as it has manifested immunosuppressive properties in the context of sterile inflammation (e.g., inflammatory bowel disease, rheumatoid arthritis, and neurodegenerative diseases), and immunoprotective effects during viral infections (e.g. COVID-19) Similarly, CBD has exhibited a selective response toward cancer types by engaging different targets and signaling pathways. These results are in favor of the primary function of the endocannabinoid system which is homeostatic maintenance.Conclusion: The presented evidence suggests that the endocannabinoid system is a prominent target for the treatment of inflammatory and autoimmune diseases, rheumatoid diseases, viral infections, neurological and psychological pathologies, and cancer. Moreover, the antitumoral activities of CBD have been suggested to be potentially used in combination with chemo- or immunotherapy during cancer. However, clinical results are still lacking, which raises a challenge to apply translational cannabis research to the human immune system.
引用
收藏
页码:254 / 269
页数:16
相关论文
共 194 条
  • [1] Integrating cannabis into clinical cancer care
    Abrams, D. I.
    [J]. CURRENT ONCOLOGY, 2016, 23 : S8 - S14
  • [2] *Endocannabinoid system acts as a regulator of immune homeostasis in the gut
    Acharya, Nandini
    Penukonda, Sasi
    Shcheglova, Tatiana
    Hagymasi, Adam T.
    Basu, Sreyashi
    Srivastava, Pramod K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (19) : 5005 - 5010
  • [3] Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
    Afrin, Farjana
    Chi, Mengna
    Eamens, Andrew L.
    Duchatel, Ryan J.
    Douglas, Alicia M.
    Schneider, Jennifer
    Gedye, Craig
    Woldu, Ameha S.
    Dun, Matthew D.
    [J]. CANCERS, 2020, 12 (04)
  • [4] Ahmed Waseem, 2016, Gastroenterol Hepatol (N Y), V12, P668
  • [5] Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
    Alhouayek, Mireille
    Lambert, Didier M.
    Delzenne, Nathalie M.
    Cani, Patrice D.
    Muccioli, Giulio G.
    [J]. FASEB JOURNAL, 2011, 25 (08) : 2711 - 2721
  • [6] Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide
    Ali, Alaa M.
    El-Tawil, Osama S.
    Al-Mokaddem, Asmaa K.
    Abd El-Rahman, Sahar S.
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 336
  • [7] Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse
    Alves de Carvalho, Antonelly Cassio
    de Souza, Gabriela Achete
    de Marqui, Samylla Vaz
    Guiguer, Elen Landgraf
    Araujo, Adriano Cressoni
    Rubira, Claudio Jose
    Goulart, Ricardo de Alvares
    Prync Flato, Uri Adrian
    dos Santos Bueno, Patricia Cincotto
    Buchaim, Rogerio Leone
    Barbalho, Sandra M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [8] Cannabis, Cannabinoids, and the Endocannabinoid SystemIs there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose, Tim
    Simmons, Alison
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (04) : 525 - 535
  • [9] Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
    Anil, Seegehalli M.
    Shalev, Nurit
    Vinayaka, Ajjampura C.
    Nadarajan, Stalin
    Namdar, Dvora
    Belausov, Eduard
    Shoval, Irit
    Mani, Karthik Ananth
    Mechrez, Guy
    Koltai, Hinanit
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Cannabis, a complex plant: different compounds and different effects on individuals
    Atakan, Zerrin
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (06) : 241 - 254